Lanzamiento Enero 2027

Ensayo controlado aleatorizado2000Financiación no declarada

Blood pressure responses to whole-body cold exposure: effect of carvedilol

Komulainen S, Tähtinen T, Rintamäki H, Virokannas H, Keinänen-Kiukaanniemi S

European journal of clinical pharmacology · 18 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2000-10-20 · Eur J Clin Pharmacol · vol. 56 · número 9-10 · págs. 637–642
Editorial
Springer Science+Business Media
Citado
26 citas · más que el 63% de estudios similares · 0.2× el promedio de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Blood Pressure and Hypertension Studies · Thermoregulation and physiological responses · Thermal Regulation in Medicine
Palabras clave
carvedilol, cold exposure, blood pressure, heart rate, hypertension, beta-adrenergic blockade, ambulatory blood pressure monitoring
MeSH
humans, propanolamines, carbazoles, adrenergic beta-antagonists, cross-over studies, double-blind method, blood pressure, heart rate, adult, middle aged, female, male, cold temperature, hot temperature, carvedilol

5 autores

  • Silja Komulainen🇫🇮 · autor de correspondenciaUniversity of Oulu
  • Tuula Tähtinen🇫🇮University of Oulu
  • Hannu Rintamäki🇫🇮Finnish Institute of Occupational Health
  • Hannu Virokannas🇫🇮University of Oulu
  • Sirkka M Keinanen-Kiukaanniemi🇫🇮Oulu University Hospital; University of Oulu

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

The aim of this study was to test the effects of carvedilol on blood pressure (BP) and heart rate (HR) during whole-body cold exposure in hypertensive and normotensive subjects.

Methods

Ten hypertensive and twelve normotensive subjects were exposed to cold (-15 degrees C, wind 3.5 m/s) three times for 15 min with a 1-week interval between the exposures. The study design was made according to a randomised double-blind, crossover method. Before the cold exposures the subjects ingested carvedilol or placebo once a day (carvedilol 12.5 mg/day for 2 days and then 25 mg/day for 5 days) for 1 week. The systolic (SBP) and diastolic (DBP) blood pressure and HR were measured every 3 min during the test procedures using an indirect ambulatory blood pressure monitor device (ABPM-02, Meditech Co.).

Results

In the hypertensive group, the cold exposure increased SBP/DBP from 119/75 mmHg to 143/96 mmHg during carvedilol treatment (P<0.001) and from 132/85 mmHg to 159/106 mmHg during placebo (P<0.001). In the normotensive group the cold exposure increased SBP/DBP from 112/72 mmHg to 142/93 mmHg during carvedilol treatment (P<0.001) and from 121/75 mmHg to 147/98 mmHg during placebo (P<0.001). In the hypertensive group, the levels of SBP, DBP and MAP (mean arterial pressure) were significantly lower with carvedilol than with placebo during the cold exposure although carvedilol did not affect the cold-induced rise of the BP. The BPs were lower also with carvedilol in the normotensive group than the placebo during the cold exposure, but the differences were smaller than in the hypertensive group. Carvedilol decreased the BP more the higher the initial mean SBP/DBP was with placebo during the cold exposure.

Conclusion

Carvedilol reduced the BP during the cold exposure, especially in the hypertensive subjects but also in normotensive ones, without effect on the cold-induced rise of the BP.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.